Increase in plasma melatonin, β-endorphin, and cortisol after a 28.5-mile mountain race

Relationship to performance and lack of effect of naltrexone

R. J. Strassman, O. Appenzeller, Alfred Lewy, C. R. Qualls, G. T. Peake

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Strenuous exercise increases plasma melatonin, cortisol, and β-endorphin concentrations. Furthermore, a relationship between endogenous opioids and melatonin has been proposed. We measured plasma melatonin, cortisol, and β-endorphin in 46 subjects before and after a 28.5-mile high altitude race. Thirteen of the subjects received the orally active opioid antagonist naltrexone immediately before the race. The mean plasma melatonin, cortisol, and β-endorphin levels were higher after the race than before it; the melatonin results were confirmed by gas chromatography-mass spectrometry assay of 12 subjects. Naltrexone had no effect on the increase in any of the three hormones. The run-induced increases in plasma melatonin, β-endorphin, and cortisol were negatively correlated with finishing time, but only the plasma β-endorphin and cortisol rises correlated with each other. We conclude that prolonged exercise in trained athletes can increase plasma melatonin and that this rise is not due to the concomitant opioid release.

Original languageEnglish (US)
Pages (from-to)540-545
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume69
Issue number3
StatePublished - 1989

Fingerprint

Endorphins
Naltrexone
Melatonin
Hydrocortisone
Plasmas
Opioid Analgesics
Exercise
Narcotic Antagonists
Athletes
Gas chromatography
Gas Chromatography-Mass Spectrometry
Mass spectrometry
Assays
Hormones

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Increase in plasma melatonin, β-endorphin, and cortisol after a 28.5-mile mountain race : Relationship to performance and lack of effect of naltrexone. / Strassman, R. J.; Appenzeller, O.; Lewy, Alfred; Qualls, C. R.; Peake, G. T.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 69, No. 3, 1989, p. 540-545.

Research output: Contribution to journalArticle

@article{ff9bc15a730444cab14228a38d7b30de,
title = "Increase in plasma melatonin, β-endorphin, and cortisol after a 28.5-mile mountain race: Relationship to performance and lack of effect of naltrexone",
abstract = "Strenuous exercise increases plasma melatonin, cortisol, and β-endorphin concentrations. Furthermore, a relationship between endogenous opioids and melatonin has been proposed. We measured plasma melatonin, cortisol, and β-endorphin in 46 subjects before and after a 28.5-mile high altitude race. Thirteen of the subjects received the orally active opioid antagonist naltrexone immediately before the race. The mean plasma melatonin, cortisol, and β-endorphin levels were higher after the race than before it; the melatonin results were confirmed by gas chromatography-mass spectrometry assay of 12 subjects. Naltrexone had no effect on the increase in any of the three hormones. The run-induced increases in plasma melatonin, β-endorphin, and cortisol were negatively correlated with finishing time, but only the plasma β-endorphin and cortisol rises correlated with each other. We conclude that prolonged exercise in trained athletes can increase plasma melatonin and that this rise is not due to the concomitant opioid release.",
author = "Strassman, {R. J.} and O. Appenzeller and Alfred Lewy and Qualls, {C. R.} and Peake, {G. T.}",
year = "1989",
language = "English (US)",
volume = "69",
pages = "540--545",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Increase in plasma melatonin, β-endorphin, and cortisol after a 28.5-mile mountain race

T2 - Relationship to performance and lack of effect of naltrexone

AU - Strassman, R. J.

AU - Appenzeller, O.

AU - Lewy, Alfred

AU - Qualls, C. R.

AU - Peake, G. T.

PY - 1989

Y1 - 1989

N2 - Strenuous exercise increases plasma melatonin, cortisol, and β-endorphin concentrations. Furthermore, a relationship between endogenous opioids and melatonin has been proposed. We measured plasma melatonin, cortisol, and β-endorphin in 46 subjects before and after a 28.5-mile high altitude race. Thirteen of the subjects received the orally active opioid antagonist naltrexone immediately before the race. The mean plasma melatonin, cortisol, and β-endorphin levels were higher after the race than before it; the melatonin results were confirmed by gas chromatography-mass spectrometry assay of 12 subjects. Naltrexone had no effect on the increase in any of the three hormones. The run-induced increases in plasma melatonin, β-endorphin, and cortisol were negatively correlated with finishing time, but only the plasma β-endorphin and cortisol rises correlated with each other. We conclude that prolonged exercise in trained athletes can increase plasma melatonin and that this rise is not due to the concomitant opioid release.

AB - Strenuous exercise increases plasma melatonin, cortisol, and β-endorphin concentrations. Furthermore, a relationship between endogenous opioids and melatonin has been proposed. We measured plasma melatonin, cortisol, and β-endorphin in 46 subjects before and after a 28.5-mile high altitude race. Thirteen of the subjects received the orally active opioid antagonist naltrexone immediately before the race. The mean plasma melatonin, cortisol, and β-endorphin levels were higher after the race than before it; the melatonin results were confirmed by gas chromatography-mass spectrometry assay of 12 subjects. Naltrexone had no effect on the increase in any of the three hormones. The run-induced increases in plasma melatonin, β-endorphin, and cortisol were negatively correlated with finishing time, but only the plasma β-endorphin and cortisol rises correlated with each other. We conclude that prolonged exercise in trained athletes can increase plasma melatonin and that this rise is not due to the concomitant opioid release.

UR - http://www.scopus.com/inward/record.url?scp=0024468134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024468134&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 540

EP - 545

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -